Today, the U.S. Food and Drug Administration (FDA) issued the “Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan” from the Center for Devices and Radiological Health’s Digital Health Center of Excellence.
Browsing: News
Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, has announced a strategic collaboration with Almac Diagnostic Services, a global stratified medicine company, to enhance opportunities for clinical trial development and companion diagnostic (CDx) projects.
Broome Oncology LLC and Deep Lens announced that the two companies are collaborating on an initiative to rapidly and effectively match patients to precision therapies and clinical studies with Deep Lens’ artificial intelligence-based screening and enrollment platform, called VIPER.
Tempus ONE is the first step toward bringing the full power of artificial intelligence to the point-of-care.
AI Metrics LLC, a medical imaging startup focused on augmented intelligence to improve patient care, announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s flagship image analysis platform.
The Strategic Radiology (SR) coalition of independent practices has recruited one of its own, neuroradiologist Scott Bundy, MD, FACR, as CEO, replacing Arl Van Moore Jr., MD, FACR, who retired this month as CEO and Chair.
NorthStar Medical Radioisotopes LLC, a global innovator in the production and distribution of radiopharmaceuticals used for medical imaging and therapeutic treatments, today announced that the U.S. Food and Drug Administration (FDA) has approved its application for producing Mo-99 from concentrated Mo-98 (cMo-98) and related software updates for the RadioGenix® System (technetium Tc 99m generator).
Konica Minolta Healthcare Americas Inc. and strategic partner AGIMED, a leading healthcare distributor in Argentina, jointly announce the implementation of Konica Minolta imaging management solutions across the primary public health hospital system in Córdoba, Argentina’s second largest region.
Elo, a provider of interactive solutions, has announced a set of DICOM Part 14-compliant medical-grade touchscreen monitors designed to enhance clinical review for hospitals, clinics, pharmacies and health care providers seeking to speed their workflow with the benefits of interactivity.
Hologic Inc. announced that it has agreed to acquire Biotheranostics Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million, subject to working capital and other customary closing adjustments.
